https://www.selleckchem.com/products/dac51.html
BACKGROUND Intradermal botolinum toxin A (BTXA) is an advanced technique that emerged in response to the increased demand for noninvasive facial lifting and skin rejuvenation. OBJECTIVE We sought to evaluate the safety and efficacy of intradermal injections of BTXA for facial lifting. METHODS Twenty-five female patients with mild symmetrical facial skin laxity were enrolled in this study. All patients were treated with BTXA in one side of the face while the other side was injected with normal saline. The response to treatment was assessed
Like
Comment
Share
